They hope that might bring someone to justice. It's likely to do the reverse.
In the space between trauma and justice, a Bristol company offered sexual assault survivors a tool they hoped would give them agency — DNA self-swab kits promising to preserve evidence outside the formal reporting system. Britain's Advertising Standards Authority has now ruled that the promises made to sell those kits were not grounded in fact: claims about court admissibility were unsubstantiated, and statistics about the scale of sexual violence in the UK were exaggerated. The ruling arrives with a particular weight, because the people who believed those claims were not ordinary consumers making ordinary purchases — they were survivors, acting in hope.
- A company sold £20 DNA kits to sexual assault survivors with the suggestion that home-collected evidence could hold up in court — a claim forensic experts and regulators now say was never true.
- The Advertising Standards Authority banned all promotional materials after finding that Enough could not substantiate its core claims, including that 430,000 rapes occur annually in the UK and that women are twice as likely to be raped as diagnosed with cancer.
- Sir Martin Narey, former head of England and Wales's Prison and Probation Services, filed the complaint, warning that the kits were not empowering survivors but potentially leading them away from the forensic pathways most likely to deliver justice.
- Forensic medicine specialists had already raised alarms in 2024, cautioning that self-collected evidence risks contamination and could actively undermine legal cases rather than support them.
- Enough has revised its language following the ban, but the harm may already be done — survivors who purchased kits believing they were building a case now face the possibility that their evidence is inadmissible, or worse, counterproductive.
In May 2026, Britain's Advertising Standards Authority banned promotional materials from Enough, a Bristol-based organisation selling DNA self-swab kits to sexual assault survivors. The company had marketed the kits — available free to Bristol students and for £20 online — as a way for survivors to collect and store DNA evidence without involving the police. Its adverts claimed this evidence would be admissible in court and cited figures suggesting over 430,000 rapes occur annually in the UK, with women twice as likely to be raped as diagnosed with cancer.
The complaint was filed by Sir Martin Narey, former head of England and Wales's Prison and Probation Services, who argued the company was frightening young women and their families while overstating both the risk of assault and the legal value of the kits. His concern was precise: survivors were spending money and placing hope in a product that was unlikely to help them in court, and might actively harm their case.
The ASA upheld all three complaints, finding that Enough had not provided adequate evidence for any of its central claims. Forensic experts had already warned in September 2024 that self-collected swabs, gathered outside the controlled protocols of sexual assault referral centres, risked contamination and could undermine prosecutions. The Faculty of Forensic and Legal Medicine stated plainly that such kits could put survivors at risk.
Following the ruling, Enough revised its language — describing rape figures as estimates and admissibility as a matter of principle rather than certainty. But the deeper consequence remained: survivors who had purchased the kits in good faith, believing they were taking a meaningful step toward justice, now faced the possibility that what they had collected could not be used — or could even work against them.
In May, Britain's advertising watchdog moved to stop a company from promoting DNA self-swab kits to sexual assault survivors by claiming the evidence could be used in court. The Advertising Standards Authority ruled that Enough, a Bristol-based organization, had made unsubstantiated claims across its website, LinkedIn posts, and fundraising pages about how courts would treat evidence collected at home and about the scale of sexual violence in the UK.
Enough had launched the kits with a straightforward premise: survivors could swab for DNA evidence themselves, have it tested, and store the results—all without reporting to police. The company distributed them free to Bristol students and sold them online for £20 each. Behind the initiative lay a stark calculation about reporting rates. Official figures from the Office for National Statistics showed 71,227 rapes reported to police in 2024, but Enough argued the true number was far higher when accounting for unreported incidents. The company claimed 430,000 rapes occurred annually in the UK and stated that women were twice as likely to be raped as diagnosed with cancer.
Sir Martin Narey, the former head of England and Wales's Prison and Probation Services, filed the complaint that triggered the investigation. He had grown concerned that Enough was frightening young women and their parents by exaggerating both the likelihood of sexual assault and the utility of the kits themselves. What troubled him most, he said, was the suggestion that home-collected DNA evidence would be admissible in court. "The awful truth is that young women and parents have bought these kits in the hope that it might help in the awful event of their daughter being harmed," Narey explained. "They hope that that might bring someone to justice. It's likely to do the reverse."
The ASA upheld all three complaints. The authority found that Enough had not provided adequate evidence to support its claims about court admissibility, the annual number of rapes in the UK, or the comparative likelihood of rape versus cancer diagnosis. Miles Lockwood, the ASA's director of complaints and investigations, said the core problem was that Enough had created an impression of reliability that the evidence did not support. "They didn't have the evidence to make the claims that were in the ad, and that's why we banned them," he said. The ruling was particularly significant given the vulnerability of the audience: people making decisions about evidence collection following trauma.
Forensic experts had already raised red flags. In September 2024, the Faculty of Forensic and Legal Medicine issued a joint statement opposing the use of self-swab kits, warning they could "put survivors at risk" without proper guidance. The organization noted that evidence collected outside established forensic protocols—such as those used by sexual assault referral centres—risked contamination and could undermine rather than strengthen legal cases. Enough had countered that the kits served a purpose for people unwilling or unable to report through official channels, framing them as a response to what it called an "intolerable" gap in support.
Following the ban, Enough said it respected the ruling and had revised its language. The company now refers to "estimated" rape figures rather than stating them as fact, and describes its kits as potentially admissible in court "in principle" rather than claiming they will be. A spokesperson acknowledged that police and sexual assault referral centres "remain the best and most comprehensive option where survivors feel able to access them." The damage, however, had already been done. Survivors who purchased the kits in the belief they were taking a practical step toward justice now faced the possibility that the evidence they collected would be inadmissible—and might even harm their case if they later chose to report.
Notable Quotes
They didn't have the evidence to make the claims that were in the ad, and that's why we banned them.— Miles Lockwood, ASA director of complaints and investigations
The awful truth is that young women and parents have bought these kits in the hope that it might help in the awful event of their daughter being harmed. They hope that that might bring someone to justice. It's likely to do the reverse.— Sir Martin Narey, former head of Prison and Probation Services
The Hearth Conversation Another angle on the story
Why would a company make claims about court admissibility if they didn't have legal backing for them?
Because the emotional logic was compelling. They were selling hope to people in crisis. The kits themselves are real—DNA collection is straightforward. But the leap from "we can collect your DNA" to "this will be admissible in court" required legal certainty they simply didn't have.
Did Enough knowingly mislead people, or did they genuinely believe their own claims?
The ASA didn't investigate intent, only whether the claims were substantiated. What matters more is the effect: people bought these kits believing they were taking a legitimate forensic step. That belief was the product being sold.
The rape statistics—why inflate them?
Not necessarily inflation in the malicious sense. Enough was arguing that official numbers undercount because so many assaults go unreported. That's a real argument. But they presented estimates as established fact, and that crossed a line.
What happens to someone who already bought a kit?
They have evidence they collected at home, outside any chain of custody, that a court is unlikely to accept. If they later report to police, they've potentially contaminated their own case. That's the cruelty of it.
Could these kits ever work as Enough intended?
Only if the legal system changed to accept them, which seems unlikely. Forensic evidence requires strict protocols for a reason. Self-collection breaks those protocols. Enough was trying to solve a real problem—the trauma of formal reporting—but chose a tool that can't actually do what they promised.